Hepatocellular Carcinoma Update
Lung Cancer — 5-Minute Journal Club Issue 4 with Dr Aaron Lisberg: Defining the Role of TROP2-Directed Antibody-Drug Conjugates
- Autor: Vários
- Narrador: Vários
- Editora: Podcast
- Duração: 0:21:21
- Mais informações
Informações:
Sinopse
Dr Aaron Lisberg from the University of California, Los Angeles, discusses recent developments with TROP2-directed antibody-drug conjugates in the management of non-small cell lung cancer. CME information and select publications here.
